Bristol-Myers Squibb: A Biopharma Turnaround Fueled by Earnings Momentum - AInvest
17 hours ago • Google News
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology,.
17 hours ago • Google News
20 hours ago • Google News
4 days ago • Google News
ESG data provided by Sustainalytics, Inc.